{
  "url": "https://openlegislation.uk/eu-regulation-2012-618/annex-IV",
  "json_url": "https://openlegislation.uk/eu-regulation-2012-618/annex-IV.json",
  "legislation": "eur/2012/618",
  "legislation_title": "Commission Regulation (EU) No 618/2012 of 10 July 2012 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2012-618",
  "path": "annex/IV",
  "kind": "annex",
  "number": "IV",
  "heading": null,
  "text": "Index No\nInternational Chemical Identification\nEC No\nCAS No\nClassification\nLabelling\nConcentration Limits\nNotes\n‘015-199-00-X\ntris[2-chloro-1-chloromethyl)ethyl] phosphate\n237-159-2\n13674-87-8\nCarc. Cat. 3; R40\nXn\nR: 40\nS: (2-)36/37\n015-200-00-3\nindium phosphide\n244-959-5\n22398-80-7\nCarc. Cat. 2; R45\nRepr. Cat. 3; R62\nT; R48/23\nT\nR: 45–48/23–62\nS: 45- 53\nT; R48/23: C ≥0,1%\nCarc Cat 2; R45: C ≥0,01%\nXn; R48/20: 0,01%≤ C < 0,1%\nE\n015-201-00-9\ntrixylyl phosphate\n246-677-8\n25155-23-1\nRepr. Cat. 2; R60\nT\nR: 60\nS: 53-45\n015-202-00-4\ntris(nonylphenyl) phosphite\n247-759-6\n26523-78-4\nXi; R43\nN; R50-53\nXi; N\nR: 43-50/53\nS: 24-37-60-61\n015-203-00-X\ndiphenyl(2,4,6-trimethylbenzoyl)phosphine oxide\n278-355-8\n75980-60-8\nRepr. Cat. 3; R62\nXn\nR: 62\nS: (2)-22-36/37.\n602-109-00-4\nHexabromocyclododecane [1]\n247-148-4 [1]\n25637-99-4[1]\nRepr. Cat. 3; R63 R64\nXn\nR: 63-64\nS: 36/37-53\n1,2,5,6,9,10-hexabromocyclododecane [2]\n221-695-9[2]\n3194-55-6[2]\n606-143-00-0\nabamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1]\n_ [1]\n71751-41-2 [1]\nRepr. Cat. 3; R63\nT+; R26/28\nT; R48/23/25\nN; R50-53\nT+; N\nR: 63-26/28-48/23/25-50/53\nS: 28-36/37-45-60-61\nT; R48/23: C ≥ 5%\nXn; R48/20: 0,5% ≤ C <5%\nN; R50-53: C ≥ 0,0025%\nN; R51-53: 0,00025% ≤ C <0,0025%\nR52-53: 0,000025% ≤ C<0,00025%\navermectin B1a (purity ≥80%); [2]\n265-610-3 [2]\n65195-55-3 [2]\n606-144-00-6\nacequinocyl (ISO);\n3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate\n—\n57960-19-7\nT; R39/23\nXi; R43\nN; R50-53\nT; N\nR: 39/23-43-50/53,\nS: (2-)24-37-38-60-61\nN; R50-53: C ≥ 0,025%\nN; R51-53: 0,0025% ≤ C < 0,025%\nR52-53: 0,00025% ≤ C < 0,0025%\n607-698-00-1\n4-tert-butylbenzoic acid\n202-696-3\n98-73-7\nRepr. Cat. 2; R60\nT; R48/23/24/25\nXn; R22\nT\nR: 60-22-48/23/24/25\nS: 53-45\nE\n612-281-00-2\nleucomalachite green\nN,N,N',N'-tetramethyl-4,4'-benzylidenedianiline\n204-961-9\n129-73-7\nCarc. Cat. 3; R40\nMuta. Cat. 3; R68\nXn\nR: 40-68\nS: (2-)36/37\n616-205-00-9\nMetazachlor (ISO);\n2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide\n266-583-0\n67129-08-2\nR43\nCarc. Cat. 3; R40\nN; R50-53\nXn; N\nR: 40-43-50/53\nS: (2-)36-37-60-61\nN; R50-53: C ≥ 0,25%\nN; R51-53: 0,025% ≤ C < 0,25%\nR52-53: 0,0025% ≤ C < 0,025%’",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2012/618/annex/IV",
    "retrieved_at": "2026-11-01T14:49:19.760174+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}